Cargando…
Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities
MYBPC3 mutations cause hypertrophic cardiomyopathy, which is frequently associated with mitral valve (MV) pathology. We reasoned that increased MV size is caused by localized growth factors with paracrine effects. We used high-resolution echocardiography to compare Mybpc3-null, heterozygous, and wil...
Autores principales: | Judge, Daniel P., Neamatalla, Hany, Norris, Russell A., Levine, Robert A., Butcher, Jonathan T., Vignier, Nicolas, Kang, Kevin H., Nguyen, Quangtung, Bruneval, Patrick, Perier, Marie-Cécile, Messas, Emmanuel, Jeunemaitre, Xavier, de Vlaming, Annemarieke, Markwald, Roger, Carrier, Lucie, Hagège, Albert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725593/ https://www.ncbi.nlm.nih.gov/pubmed/26819945 http://dx.doi.org/10.3390/jcdd2020048 |
Ejemplares similares
-
Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice
por: Fraysse, Bodvaël, et al.
Publicado: (2012) -
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
por: Gedicke-Hornung, Christina, et al.
Publicado: (2013) -
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
por: Friedrich, Felix W., et al.
Publicado: (2016) -
Mutations in DCHS1 Cause Mitral Valve Prolapse
por: Durst, Ronen, et al.
Publicado: (2015) -
Investigation of the Matrix Metalloproteinase-2 Gene in Patients with Non-Syndromic Mitral Valve Prolapse
por: Perrocheau, Maëlle, et al.
Publicado: (2015)